These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9641003)

  • 41. Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics of pioglitazone.
    Jaakkola T; Backman JT; Neuvonen M; Neuvonen PJ
    Clin Pharmacol Ther; 2005 May; 77(5):404-14. PubMed ID: 15900286
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetic consequences of long term coadministration of cimetidine and triazolobenzodiazepines, alprazolam and triazolam, in healthy subjects.
    Pourbaix S; Desager JP; Hulhoven R; Smith RB; Harvengt C
    Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):447-51. PubMed ID: 2864320
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Single-dose pharmacokinetics and pharmacodynamics of alprazolam in elderly and young subjects.
    Kaplan GB; Greenblatt DJ; Ehrenberg BL; Goddard JE; Harmatz JS; Shader RI
    J Clin Pharmacol; 1998 Jan; 38(1):14-21. PubMed ID: 9597554
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The pharmacology of alprazolam: a review.
    Huybrechts I
    Clin Ther; 1991; 13(1):100-17. PubMed ID: 2029716
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Disposition of alprazolam in human volunteers. Differences between genders.
    Kristjánsson F; Thorsteinsson SB
    Acta Pharm Nord; 1991; 3(4):249-50. PubMed ID: 1781916
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Symptomatic hypotension with venlafaxine-benzodiazepine interaction.
    Yazici K; Buturak V; Yazici AE; Tot S
    Int J Psychiatry Clin Pract; 2003; 7(4):273-6. PubMed ID: 24930414
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of tofisopam on the single-oral-dose pharmacokinetics and pharmacodynamics of the cyp3a4 probe drug alprazolam.
    Drabant S; Tóth M; Bereczki A; Bajnógel J; Tömlö J; Klebovich I
    Eur J Clin Pharmacol; 2006 Jul; 62(7):587-8. PubMed ID: 16791582
    [No Abstract]   [Full Text] [Related]  

  • 48. Differences in pharmacodynamics but not pharmacokinetics between subjects with panic disorder and healthy subjects after treatment with a single dose of alprazolam.
    Kaplan GB; Greenblatt DJ; Ehrenberg BL; Goddard JE; Harmatz JS; Shader RI
    J Clin Psychopharmacol; 2000 Jun; 20(3):338-46. PubMed ID: 10831021
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of alosetron on the pharmacokinetics of alprazolam.
    D'Souza DL; Levasseur LM; Nezamis J; Robbins DK; Simms L; Koch KM
    J Clin Pharmacol; 2001 Apr; 41(4):452-4. PubMed ID: 11304902
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical pharmacokinetics of alprazolam. Therapeutic implications.
    Greenblatt DJ; Wright CE
    Clin Pharmacokinet; 1993 Jun; 24(6):453-71. PubMed ID: 8513649
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Venlafaxine.
    Shuster J
    Nursing; 1996 Mar; 26(3):27. PubMed ID: 8700462
    [No Abstract]   [Full Text] [Related]  

  • 52. Pharmacokinetic interaction between multiple-dose venlafaxine and single-dose lithium.
    Troy SM; Parker VD; Hicks DR; Boudino FD; Chiang ST
    J Clin Pharmacol; 1996 Feb; 36(2):175-81. PubMed ID: 8852394
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alprazolam in young and elderly men: sensitivity and tolerance to psychomotor, sedative and memory effects.
    Bertz RJ; Kroboth PD; Kroboth FJ; Reynolds IJ; Salek F; Wright CE; Smith RB
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1317-29. PubMed ID: 9190868
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of plasma concentration of micro-RNA Mir-27b and CYP3A4*22 on equilibrium concentration of alprazolam in patients with anxiety disorders comorbid with alcohol use disorder.
    Zastrozhin MS; Skryabin VY; Smirnov VV; Petukhov AE; Pankratenko EP; Zastrozhina AK; Grishina EA; Ryzhikova KA; Bure IV; Golovinskii PA; Koporov SG; Bryun EA; Sychev DA
    Gene; 2020 May; 739():144513. PubMed ID: 32112986
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship between single oral dose pharmacokinetics of alprazolam and triazolam.
    Otani K; Yasui N; Furukori H; Kaneko S; Tasaki H; Ohkubo T; Nagasaki T; Sugawara K; Hayashi K
    Int Clin Psychopharmacol; 1997 May; 12(3):153-7. PubMed ID: 9248872
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Introduction of a composite parameter to the pharmacokinetics of venlafaxine and its active O-desmethyl metabolite.
    Klamerus KJ; Maloney K; Rudolph RL; Sisenwine SF; Jusko WJ; Chiang ST
    J Clin Pharmacol; 1992 Aug; 32(8):716-24. PubMed ID: 1487561
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alprazolam in the elderly: pharmacokinetics and pharmacodynamics during multiple dosing.
    Kroboth PD; McAuley JW; Smith RB
    Psychopharmacology (Berl); 1990; 100(4):477-84. PubMed ID: 2320708
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug-induced pneumonitis and heart failure simultaneously associated with venlafaxine.
    Drent M; Singh S; Gorgels AP; Hansell DM; Bekers O; Nicholson AG; van Suylen RJ; du Bois RM
    Am J Respir Crit Care Med; 2003 Apr; 167(7):958-61. PubMed ID: 12663337
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The pharmacokinetics of venlafaxine when given in a twice-daily regimen.
    Troy SM; Parker VD; Fruncillo RJ; Chiang ST
    J Clin Pharmacol; 1995 Apr; 35(4):404-9. PubMed ID: 7650231
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of CYP3A5*3 genotype on the pharmacokinetics and pharmacodynamics of alprazolam in healthy subjects.
    Park JY; Kim KA; Park PW; Lee OJ; Kang DK; Shon JH; Liu KH; Shin JG
    Clin Pharmacol Ther; 2006 Jun; 79(6):590-9. PubMed ID: 16765147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.